ACAD — ACADIA PHARMACEUTICAL
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $1.2B | +14.8% | $362.2M | +38.9% | 26.1% | — | 15.6% | — | — | — | — |
Revenue YoY trend Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | 0.28 | 16.4× | 0.53 | 0.18 | 8 | +3−2 |
| Mar 2027 | 0.20 | 22.9× | 0.35 | 0.09 | 3 | +1 |
| Jun 2027 | 0.21 | 21.8× | 0.35 | 0.12 | 3 | +1 |
| Sep 2027 | 0.22 | 20.8× | 0.37 | 0.14 | 3 | +1 |
| Dec 2027 | 0.24 | 19.1× | 0.37 | 0.15 | 3 | +1 |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | 0.76 | 24.1× | 1.04 | 0.56 | 8 | +5−1 |
| Dec 2027 | 1.08 | 17.0× | 1.87 | 0.50 | 8 | +3−2 |
| Dec 2028 | 1.69 | 10.8× | 2.93 | 0.98 | 5 | +1 |
| Dec 2029 | 1.94 | 9.4× | 3.26 | 1.04 | 3 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 363 SEC-registered investment managers reported holding ACAD (ACADIA PHARMACEUTICAL) in their latest 13F filings, with a combined reported value of $3.39B across 168.15M shares. That is +2.6% by share count (+4.00M shares) versus the previous quarter, while reported value moved -18.2%. Ownership is concentrated: the five largest holders account for 53.6% of reported value and the top ten for 65.2%.
Compared with the prior quarter, 66 opened new positions, 148 added to existing stakes, 89 trimmed, 63 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ACADIA PHARMACEUTICAL (ACAD) include BAKER BROS. ADVISORS LP, BlackRock Inc, Vanguard Group, ranked by reported 13F value among the 639 institutional holders on this page.
ACAD is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 363 | 168.15M | $3.39B | +2.0% |
| Q2 2026 | 358 | 164.35M | $4.15B | +0.9% |
| Q1 2026 | 351 | 165.36M | $3.67B | -2.2% |
| Q4 2025 | 343 | 169.39M | $4.51B | -3.1% |
| Q3 2025 | 343 | 173.85M | $3.69B | +0.6% |
| Q2 2025 | 312 | 167.96M | $3.60B | -3.3% |
| Q1 2025 | 316 | 173.63M | $2.87B | +2.7% |
| Q4 2024 | 290 | 162.82M | $2.97B | +1.6% |
Over the 8 quarters shown, institutional share counts increased 3% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (-3.3%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 42.91M | $864.70M | 4.19% | Hold | |
| 22.95M | $462.39M | 0.01% | Add | |
| 9.46M | $190.56M | 0.01% | Add | |
| 7.65M | $154.17M | 0.01% | Reduce | |
| 7.14M | $143.96M | 1.45% | Hold | |
| 5.79M | $116.68M | 0.00% | Hold | |
| 4.62M | $93.13M | 0.03% | Add | |
| 3.37M | $67.97M | 0.00% | Hold | |
| 3.37M | $67.83M | 0.01% | Reduce | |
| 2.49M | $50.09M | 7.45% | Reduce | |
| 2.46M | $49.66M | 0.10% | Add | |
| 2.18M | $43.99M | 0.06% | Add | |
| 2.14M | $43.03M | 0.06% | Add | |
| 2.14M | $43.03M | 0.06% | Add | |
| 2.13M | $42.91M | 0.02% | Add | |
| 1.53M | $30.44M | 0.05% | Add | |
| 1.48M | $29.84M | 0.00% | Add | |
| 1.44M | $28.98M | 0.74% | Hold | |
| 1.36M | $27.47M | 0.00% | Hold | |
| 1.33M | $26.73M | 0.01% | Reduce | |
| 1.31M | $26.49M | 0.00% | Add | |
| 1.31M | $26.49M | 0.00% | Add | |
| 1.15M | $23.21M | 0.05% | Add | |
| 1.11M | $22.32M | 0.03% | Reduce | |
| 1.01M | $20.32M | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 42.91M | $1.09B | 5.68% | Hold | |
| 22.52M | $569.63M | 0.01% | Add | |
| 8.84M | $223.61M | 0.01% | Add | |
| 7.14M | $180.76M | 1.54% | Hold | |
| 5.76M | $145.82M | 0.00% | Add | |
| 3.69M | $93.48M | 0.02% | Add | |
| 3.36M | $84.98M | 0.01% | New | |
| 3.36M | $84.98M | 0.01% | Reduce | |
| 2.86M | $72.46M | 10.01% | Hold | |
| 2.58M | $65.28M | 0.02% | Add | |
| 2.45M | $61.90M | 0.12% | Add | |
| 1.98M | $50.15M | 0.05% | Reduce | |
| 1.97M | $49.83M | 0.02% | Add | |
| 1.76M | $44.65M | 0.08% | Add | |
| 1.70M | $42.96M | 0.02% | Add | |
| 1.70M | $42.96M | 0.06% | Add | |
| 1.65M | $41.65M | 1.64% | Reduce | |
| 1.62M | $41.07M | 0.00% | Add | |
| 1.44M | $36.39M | 0.79% | Hold | |
| 1.37M | $34.60M | 0.00% | Add | |
| 1.35M | $34.11M | 0.01% | Add | |
| 1.33M | $33.53M | 0.06% | Reduce | |
| 1.30M | $32.90M | 0.00% | Reduce | |
| 1.28M | $32.45M | 0.04% | Reduce | |
| 1.21M | $30.52M | 0.00% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 42.90M | $954.88M | 5.78% | Hold | |
| 21.55M | $479.72M | 0.01% | Add | |
| 8.67M | $193.03M | 0.01% | New | |
| 8.33M | $185.49M | 0.01% | Add | |
| 7.14M | $159.04M | 1.58% | Hold | |
| 5.66M | $126.02M | 0.00% | New | |
| 3.46M | $77.14M | 0.01% | Add | |
| 3.34M | $74.43M | 0.05% | Add | |
| 3.16M | $70.22M | 0.01% | Add | |
| 2.87M | $63.95M | 9.78% | Add | |
| 2.47M | $55.01M | 2.08% | Add | |
| 2.03M | $44.74M | 0.05% | Add | |
| 1.72M | $38.38M | 0.06% | Add | |
| 1.57M | $34.94M | 0.02% | Add | |
| 1.56M | $34.68M | 0.01% | Reduce | |
| 1.55M | $34.59M | 0.00% | Add | |
| 1.44M | $32.01M | 0.82% | Add | |
| 1.33M | $29.65M | 0.05% | New | |
| 1.28M | $28.43M | 0.12% | Reduce | |
| 1.27M | $28.33M | 0.00% | Add | |
| 1.17M | $26.12M | 0.00% | Hold | |
| 1.17M | $26.12M | 0.00% | Hold | |
| 1.09M | $24.33M | 0.00% | Reduce | |
| 1.04M | $23.08M | 0.01% | Reduce | |
| 1.03M | $22.87M | 0.04% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 42.90M | $1.15B | 7.03% | Hold | |
| 20.76M | $554.38M | 0.01% | Add | |
| 15.15M | $404.76M | 0.01% | Hold | |
| 7.91M | $211.30M | 0.01% | Add | |
| 7.14M | $190.83M | 1.91% | Hold | |
| 3.38M | $90.21M | 0.34% | Add | |
| 3.24M | $86.54M | 0.01% | Add | |
| 2.92M | $78.02M | 0.02% | Add | |
| 2.48M | $66.35M | 9.24% | Add | |
| 2.27M | $60.63M | 0.04% | Add | |
| 2.03M | $54.28M | 1.85% | Reduce | |
| 1.57M | $41.94M | 0.02% | Add | |
| 1.56M | $41.67M | 0.16% | Hold | |
| 1.55M | $41.49M | 0.04% | Add | |
| 1.53M | $40.94M | 0.06% | Add | |
| 1.51M | $40.27M | 0.00% | Add | |
| 1.50M | $40.13M | 0.02% | Reduce | |
| 1.42M | $37.91M | 9.37% | New | |
| 1.30M | $34.65M | 0.93% | Add | |
| 1.24M | $33.01M | 0.00% | Reduce | |
| 1.22M | $32.62M | 0.00% | Add | |
| 1.20M | $32.12M | 0.07% | Add | |
| 1.17M | $31.31M | 0.01% | Reduce | |
| 1.17M | $31.31M | 0.01% | Reduce | |
| 1.14M | $30.50M | 0.00% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 42.90M | $915.42M | 6.81% | Hold | |
| 20.27M | $432.53M | 0.01% | Reduce | |
| 15.18M | $323.93M | 0.01% | Reduce | |
| 7.26M | $154.83M | 0.01% | Add | |
| 7.14M | $152.46M | 1.88% | Reduce | |
| 3.13M | $66.86M | 0.00% | Add | |
| 2.80M | $59.71M | 0.01% | Add | |
| 2.48M | $53.01M | 0.08% | Add | |
| 2.47M | $52.64M | 9.74% | Reduce | |
| 2.38M | $50.76M | 1.60% | New | |
| 2.36M | $50.34M | 0.08% | Add | |
| 1.94M | $41.47M | 0.03% | Reduce | |
| 1.65M | $35.19M | 0.02% | Add | |
| 1.57M | $33.59M | 0.06% | Add | |
| 1.57M | $33.44M | 0.13% | Reduce | |
| 1.56M | $33.32M | 0.07% | Reduce | |
| 1.56M | $33.32M | 0.02% | Reduce | |
| 1.52M | $32.48M | 0.01% | Add | |
| 1.50M | $32.01M | 1.23% | Hold | |
| 1.49M | $31.72M | 0.13% | Reduce | |
| 1.48M | $31.65M | 0.05% | Add | |
| 1.48M | $31.65M | 0.01% | Add | |
| 1.46M | $31.21M | 0.03% | Reduce | |
| 1.45M | $30.93M | 0.04% | Reduce | |
| 1.43M | $30.45M | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 42.90M | $925.28M | 8.98% | Hold | |
| 20.65M | $445.47M | 0.01% | Reduce | |
| 15.26M | $329.25M | 0.01% | Hold | |
| 9.00M | $194.03M | 2.76% | Add | |
| 6.18M | $133.26M | 0.01% | Reduce | |
| 4.11M | $88.68M | 0.01% | Reduce | |
| 3.17M | $68.43M | 0.34% | Reduce | |
| 3.02M | $65.24M | 0.01% | Add | |
| 2.56M | $55.29M | 11.76% | Reduce | |
| 2.43M | $52.51M | 0.04% | Add | |
| 2.40M | $51.68M | 0.01% | Add | |
| 2.39M | $51.50M | 0.23% | Reduce | |
| 1.97M | $42.49M | 0.07% | Add | |
| 1.96M | $42.37M | 0.10% | Reduce | |
| 1.96M | $42.37M | 0.03% | Reduce | |
| 1.71M | $36.92M | 0.07% | Reduce | |
| 1.58M | $34.40M | 0.04% | Add | |
| 1.57M | $33.81M | 0.02% | Reduce | |
| 1.55M | $33.38M | 0.04% | Add | |
| 1.50M | $32.35M | 1.64% | Hold | |
| 1.47M | $31.68M | 0.00% | Add | |
| 1.30M | $28.10M | 0.00% | Reduce | |
| 1.19M | $25.67M | 0.00% | Reduce | |
| 1.19M | $25.67M | 0.00% | Reduce | |
| 1.16M | $25.12M | 0.06% | Add |
New Positions (Q3 2026)
- Y-Intercept (Hong Kong) Ltd 382.75K sh · $7.71M
- Weiss Asset Management LP 180.56K sh · $3.64M
- LMR Partners LLP 176.00K sh · $3.55M
- PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 154.77K sh · $3.12M
- Engineers Gate Manager LP 148.99K sh · $3.00M
- F/m Investments LLC 131.75K sh · $2.65M
- Neo Ivy Capital Management 107.87K sh · $2.17M
- TUDOR INVESTMENT CORP ET AL 105.34K sh · $2.12M
- ALGERT GLOBAL LLC 102.88K sh · $2.07M
- ACUTA CAPITAL PARTNERS, LLC 1.00K sh · $2.02M
- J. Goldman & Co LP 75.20K sh · $1.52M
- Wilshire Advisors LLC 74.77K sh · $1.51M
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 3.36M sh · $84.98M
- BRAIDWELL LP sold 1.65M sh · $41.65M
- Norges Bank Investment Management sold 1.62M sh · $41.07M
- Sixth Street Partners Management Company, L.P. sold 1.21M sh · $30.52M
- PSP Investments sold 435.38K sh · $11.01M
- Balyasny Asset Management sold 388.02K sh · $9.82M
- Logos Global Management LP sold 250.00K sh · $6.33M
- Tetragon Partners GP Ltd sold 167.88K sh · $4.25M
- STEMPOINT CAPITAL LP sold 143.17K sh · $3.62M
- ORBIMED ADVISORS LLC sold 137.00K sh · $3.47M
- Longaeva Partners L.P. sold 117.32K sh · $2.97M
- VOYA INVESTMENT MANAGEMENT LLC sold 81.92K sh · $2.07M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 42.91M | 42.91M | 42.90M | 42.90M | 42.90M | 42.90M | 42.88M | 42.88M | 42.88M | 42.88M | 42.86M | 42.86M | 42.86M | — | — | — | — | — | — | — |
| BlackRock Inc | 22.95M | 22.52M | 21.55M | 20.76M | 20.27M | 20.65M | 21.37M | 12.73M | 12.79M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9.46M | 8.84M | 8.67M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 7.65M | — | 8.33M | 7.91M | 7.26M | 6.18M | 6.99M | 4.52M | 5.97M | 5.80M | 6.00M | 6.47M | 5.21M | — | — | — | — | — | — | — |
| RTW INVESTMENTS, LP | 7.14M | 7.14M | 7.14M | 7.14M | 7.14M | 9.00M | 8.54M | 8.71M | 13.71M | 13.71M | 13.83M | 11.25M | 11.58M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.79M | 5.76M | 5.66M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goldman Sachs Group | 4.62M | 2.58M | 1.56M | 1.57M | 89.80K | 89.80K | 89.80K | 89.80K | 89.80K | 89.80K | 727.90K | 46.10K | 718.62K | 1.27M | 979.74K | 990.62K | 1.18M | 1.06M | 1.10M | 1.18M |
| Geode Capital Management | 3.37M | 3.36M | 3.46M | 3.24M | 3.13M | 3.02M | 2.95M | 2.88M | 2.88M | 2.84M | 2.79M | 2.69M | 2.58M | 2.49M | 2.39M | 2.30M | 2.22M | 2.16M | 2.20M | 2.16M |
| DIMENSIONAL FUND ADVISORS LP | 3.37M | 3.69M | 3.16M | 2.92M | 2.80M | 2.40M | 1.66M | 1.09M | 843.76K | 649.15K | — | 36.75K | 93.34K | — | — | — | — | — | — | — |
| Palo Alto Investors LP | 2.49M | 2.86M | 2.87M | 2.48M | 2.47M | 2.56M | 2.66M | 2.75M | 2.52M | 2.42M | 2.41M | 2.41M | 2.41M | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 2.46M | 2.45M | 950.30K | 1.20M | 596.44K | 783.85K | 649.21K | 631.42K | 419.40K | 1.11M | 644.07K | 280.26K | 212.92K | — | — | — | — | — | — | — |
| Two Sigma Investments | 2.18M | 926.99K | 775.12K | 1.12M | 665.89K | 483.10K | 816.66K | 1.24M | 1.11M | 347.72K | 30.00K | 348.73K | 70.10K | 366.79K | 106.20K | 11.14K | — | 58.80K | 240.47K | 26.10K |
| D. E. Shaw & Co., Inc. | 2.14M | 1.70M | 729.84K | 1.03M | 1.56M | 1.96M | 2.35M | 3.24M | 3.50M | 2.93M | 2.64M | 3.75M | 4.79M | — | — | — | — | — | — | — |
| D. E. Shaw & Co | 2.14M | 1.70M | 729.84K | 1.03M | 1.56M | 1.96M | 2.35M | 3.24M | 3.50M | 2.93M | 2.64M | 3.75M | 4.79M | 5.26M | 4.90M | 4.22M | 4.71M | 4.69M | 4.55M | 4.53M |
| Arrowstreet Capital | 2.13M | 1.97M | 1.57M | 1.50M | 1.65M | 336.44K | — | — | — | — | — | — | 54.90K | — | — | — | — | 61.10K | — | — |
| Allspring Global Investments Holdings, LLC | 1.53M | 1.13M | 954.86K | 658.81K | 525.42K | 430.96K | 310.33K | 41.62K | 121.62K | 108.84K | 58.85K | 147.10K | 125.09K | — | — | — | — | — | — | — |
| Morgan Stanley | 1.48M | 946.64K | 1.09M | 1.14M | 1.19M | 4.11M | 4.68M | 7.30M | 1.68M | 2.39M | 1.46M | 1.36M | 1.86M | 3.73M | 3.91M | 2.74M | 3.07M | 3.12M | 940.38K | 662.66K |
| Frazier Life Sciences Management, L.P. | 1.44M | 1.44M | 1.44M | 1.30M | 613.84K | — | 470.34K | 470.34K | 470.34K | 470.34K | 470.34K | 730.92K | 630.90K | — | — | — | — | — | — | — |
| Northern Trust Corp | 1.36M | 1.37M | 1.27M | 1.24M | 1.30M | 1.30M | 1.38M | 1.23M | 1.13M | 1.14M | 1.19M | 1.21M | 1.22M | 1.16M | 1.17M | 1.13M | 1.12M | 1.13M | 1.17M | 1.22M |
| Nuveen, LLC | 1.33M | 1.35M | 1.04M | 1.06M | 953.99K | 842.26K | 1.30M | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ACAD?
As of 2026-Q3, 363 institutional funds reported holding ACAD (ACADIA PHARMACEUTICAL) in SEC 13F filings, with a combined reported value of $3.39B.
How many shares of ACAD do institutions own?
13F filers reported 168.15M shares of ACAD, worth $3.39B in aggregate at the end of 2026-Q3.
Is institutional ownership of ACAD rising or falling?
Share counts moved +2.6% versus the prior quarter — accumulation.
Who are the top institutional holders of ACAD?
The largest 13F holders are BAKER BROS. ADVISORS LP, BlackRock Inc, Vanguard Group, VANGUARD PORTFOLIO MANAGEMENT LLC, STATE STREET CORP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ACADIA PHARMACEUTICAL?
The major shareholders of ACADIA PHARMACEUTICAL (ACAD) by reported 13F value are BAKER BROS. ADVISORS LP, BlackRock Inc, Vanguard Group, VANGUARD PORTFOLIO MANAGEMENT LLC, STATE STREET CORP, among 639 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.